As part of Icon Group, Australia’s largest dedicated provider of cancer care with an in-depth clinical trials program, Icon in Singapore is committed to providing access to research and clinical trials to patients across ASEAN.

Being able to deliver research and clinical trials opportunities is an important part of delivering the best cancer care possible. At Icon, we continue to invest in clinical trials and have played an integral role in the development of new and emerging treatments options across haematology, medical oncology and radiation oncology.

Through leveraging our international depth of experience and network of clinicians, we can continue to support our patients through their treatment and offer them opportunities across a range of national and international clinical trials. We want to ensure that you and your loved ones are well informed and have access to new emerging treatments and up-to-date research.

Clinical trials provide hope, access and opportunity for cancer patients and help us improve cancer care for people now and into the future by contributing to breakthroughs and advancements to the ways we can treat cancers.

New treatments are typically tested and developed in four different phases. Icon Cancer Centre Singapore primarily specialises in Phase II to Phase III clinical trials, and also participates in Phase I and Phase IV trials across our international network.

If you would like to find out more about how to participate in a clinical trial, please speak with your doctor to understand what options may be available and appropriate for you and your cancer diagnosis.

Please see below a list of clinical trials Icon is currently participating in, including links to the relevant clinical trial registry for further details.

To see all publicly and privately supported clinical trials being conducted in Singapore, visit hsa.gov.sg

For a list of trials available at Icon’s Australian centres please click here.